MSH6 and hereditary nonpolyposis colon cancer: Several articles highlighted an increased prevalence of MSH6 mutations representing 3.8% (95% CI 1.0–9.5%) of patients with EC compared to 2.6% (95% CI 0.5–7.4%) of patients with HNPCC tumors [167,168,169].